Keros Therapeutics, Inc. · NASDAQ:KROS

Pontifax Management 4 GP (2015) Ltd. reported a 11.80% stake in Keros Therapeutics, Inc. (Schedule 13D/A)

Event Apr 17, 2025 · Filed Apr 18, 2025

Pontifax Management 4 GP (2015) Ltd. reported a 11.80% stake in Keros Therapeutics, Inc., 4,787,331 shares, with active intent on Apr 17, 2025. Filed Apr 18, 2025 (Schedule 13D/A).

Stake
11.80%
Shares
4,787,331
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Pontifax Management 4 GP (2015) Ltd.11.80%4,787,331
Pontifax (Israel) IV, L.P.5.60%2,284,612
Pontifax (Cayman) IV, L.P.2.80%1,121,045
Pontifax (China) IV, L.P.3.00%1,226,412
Pontifax Late Stage Fund L.P.0.40%155,262
Pontifax Late Stage GP Ltd.0.40%155,262

Source

View original at SEC

Related